Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36
Go back to Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36| (NASDAQ: KALA) | Delayed: 0.90 -0.02 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.92 | 52 Week High | $ | |||
| Open | $0.94 | 52 Week Low | $ | |||
| Day High | $0.95 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $ | |||
| Volume | 18,429 | |||||

